← FDA DRUG APPROVALS

FDA NDA · NDA008983

ARFONAD

Sponsor: ROCHE

APPLICATION
NDA008983
TYPE
NDA
ORIGINAL APPROVAL
1954-04-26
LATEST ACTION
1988-04-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ARFONADDiscontinued
TRIMETHAPHAN CAMSYLATE 50MG/ML · INJECTABLE · INJECTION

Approval history

1988-04-21Labeling · Supplement 11AP
1978-06-26Labeling · Supplement 10AP
1976-05-06Labeling · Supplement 9AP
1954-04-26Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →